Axio Biosolutions Private Limited

Axio Biosolutions Private Limited - healthcare in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U73100GJ2008PTC053905 Incorporated 16 May 2008 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company healthcare MSME · Small
Revenue · FY 2024
₹19.9 Cr
▼ 17% YoY
Net loss · FY 2024
₹2.71 Cr
Net margin -13.6%
EBITDA · FY 2024
-₹1.89 Cr
EBITDA margin -9.5%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2.71 Cr
Issued & subscribed
Open charges
₹7.84 Cr
Satisfied ₹10.26 Cr
Company age
18 yrs
Est. 2008
Employees · EPFO
86
Provident fund records

About Axio Biosolutions Private Limited

Data last updated:

Axio Biosolutions Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Advamedica Inc. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 16 May 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U73100GJ2008PTC053905. Its GSTIN is 24AAHCA0497M1ZF (Gujarat). The company holds 4 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.71 Cr. It is led by directors Gourav Jagdishchandra Maheshwari and Leo Sebastian Mavely.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No 18 Gujarat Pharma Techno Park Sari – Motoda Ta: Sanand, Ahmedabad, Gujarat, India – 382220.

As per the financials filed for FY 2024, the company reported a revenue of ₹19.9 Cr, a decline of 17% compared to the previous year. For the same year it recorded a net loss of ₹2.71 Cr (net margin -13.6%) and EBITDA of -₹1.89 Cr (EBITDA margin -9.5%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 14% over five years.

The company has about 86 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: AxioBio. As per MCA filings, the company has open charges of ₹7.84 Cr and satisfied charges of ₹10.26 Cr on record. Court records list 4 cases involving the company, including 4 filed against it; 1 case is pending. The company has 11 deals on record (8 funding rounds, 3 secondary share transfers), with disclosed funding of ₹60.88 Cr; the latest was in October 2021. Its 3 peer companies in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger; the largest is Magnum Health and Safety Private Limited with revenue of ₹20.31 Cr.

Axio Biosolutions Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0018892). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website axiobio.com.

Company details

CIN U73100GJ2008PTC053905
Registration Number 053905
Incorporation Date 16 May 2008
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Parent Company Advamedica Inc
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0018892

Recognitions & Rankings of Axio Biosolutions

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-01-0018892

Contact details

Axio Biosolutions Private Limited's registered office is in Ahmedabad, Gujarat. Its website is axiobio.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Plot No 18 Gujarat Pharma Techno Park Sari – Motoda Ta: Sanand, Ahmedabad, Gujarat, India – 382220
  • Industry
    Healthcare, Medical Consumables & Supplies

To see the full contact details of Axio Biosolutions Private Limited, buy the company report.

Comprehensive company report
Axio Biosolutions Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Axio Biosolutions operates one associated brand: AxioBio. Each brand links to its own profile.

BrandDescriptionWebsite
Developer of advanced haemostat and wound care dressing productsaxiobio.com

Business activity

The main business activities of Axio Biosolutions are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Axio Biosolutions Private Limited, buy the company report.

Financials of Axio Biosolutions Private Limited

FY 2024 filings available

Axio Biosolutions Private Limited reported revenue of ₹19.9 Cr (down 17% YoY) for FY 2024.

Revenue · FY 2024
₹19.9 Cr ▼ 17%
Net loss · FY 2024
₹2.71 Cr margin -13.6%
EBITDA · FY 2024
-₹1.89 Cr margin -9.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 17%
3 years · compounded
▲ 15%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 60%
3 years · compounded
▲ 28%
5 years · compounded
▲ 22%

Revenue fell 17% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA rose 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.89 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.71 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-9.5%
Net Profit Margin-13.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Axio Biosolutions Private Limited, buy the company report.

Board of directors of Axio Biosolutions Private Limited

Axio Biosolutions has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Gourav Jagdishchandra MaheshwariDirector16 May 20188 Years 6 MonthsCurrent
Leo Sebastian MavelyDirector16 May 200818 Years 6 MonthsCurrent

Peer comparison

Axio Biosolutions Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Magnum Health and Safety Private Limited₹20.31 Cr (FY 2025)-58.0%Mumbai, Maharashtra, India
Mt.Derm Medical Products Private Limited₹20.29 Cr (FY 2025)-11.0%Guduvanchery, Tamil Nadu, India
Ashri Medico Surgicals Private Limited₹20.03 Cr (FY 2025)27.0%Indore, Madhya Pradesh, India
Axio Biosolutions Private Limitedthis company₹19.9 Cr (FY 2024)-₹2.71 Cr-13.6%-17.0%86Ahmedabad, Gujarat, India

To see the full peer comparison of Axio Biosolutions Private Limited, buy the company report.

Auditor

Axio Biosolutions Private Limited is audited by S.R. BATLIBOI & ASSOCIATES LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
S.R. BATLIBOI & ASSOCIATES LLPFY 20230101049W

Shareholding

The shareholding of Axio Biosolutions Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Axio Biosolutions Private Limited, buy the company report.

Charges & borrowings

Open charges
₹7.84 Cr
Satisfied charges
₹10.26 Cr
Breakdown by lending institutions
Others₹7.84 Cr
Technology Development Board₹1.33 Cr
Gvfl Trustee Company Private Limited₹1.09 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 May 2023100727750Others₹7.84 CrSatisfied
18 Oct 201310456848Technology Development Board₹1.33 CrSatisfied
28 Jun 201010227078Gvfl Trustee Company Private Limited₹1.09 CrSatisfied

To see the full charge records of Axio Biosolutions Private Limited, buy the company report.

Total charge records: 3 View all charges

Deals & funding

Axio Biosolutions Private Limited has 11 deals on record (8 funding rounds, 3 secondary share transfers), with disclosed funding of ₹60.88 Cr; the latest was in October 2021.

Total deals
11
Funding rounds
8
Secondary share transfers
3
Disclosed funding
₹60.88 Cr

Deals on record (5 of 11)

WhenDealAmountParties
Oct 2021Funding round₹22.05 CrInvestors: Advamedica Inc
Feb 2020Funding round₹17.71 CrInvestors: Advamedica Inc
Sep 2018Funding round₹10.8 CrInvestors: Advamedica Inc
Jun 2016Secondary share transferUndisclosedSeller: Advamedica Inc
May 2016Secondary share transferUndisclosedBuyer: Advamedica Inc
Seller: GVFL, 3 individuals

To see the full deal history of Axio Biosolutions Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Axio Biosolutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Axio Biosolutions Private Limited has a workforce of 86 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
86
Active EPFO establishments
1
Employee growth
22.9%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2786
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Axio Biosolutions Private Limited, buy the company report.

GST

Axio Biosolutions has 4 GST registrations: 2 active and 2 cancelled or inactive.

Total GSTINs
4
Active
2
Cancelled / inactive
2
GSTINStateStatusRegistered on
24AAHCA0497M1ZFGujaratActive01 Jul 2017
29AAHCA0497M2Z4KarnatakaActive13 Jul 2018

To see the full GST registrations and return filing status of Axio Biosolutions Private Limited, buy the company report.

Recent activity

Axio Biosolutions Private Limited has 9 board changes on record since 2008: 2 appointments and 7 cessations. The latest: Sebastian Joseph Mavely ceased to be Director on 26 Aug 2019.

Charges
A charge registered on 30 May 2023 via Charge ID 100727750 with Others was fully satisfied on 05 Jul 2025.
AGM
Axio Biosolutions Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Axio Biosolutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 7.84 Cr with Charge ID 100727750 was registered on 30 May 2023.
Ceased
Sebastian Joseph Mavely ceased to be Director.
Ceased
Gourav Jagdishchandra Maheshwari ceased to be Additional Director.
Appointed
Gourav Jagdishchandra Maheshwari was appointed as Director.
Ceased
Arvind Modi ceased to be Director.
Ceased
Khodabhai Kalidas Patel ceased to be Director.
Ceased
Madhukumar Amritlal Mehta ceased to be Director.
Charges
A charge registered on 28 Jun 2010 via Charge ID 10227078 with Gvfl Trustee Company Private Limited was fully satisfied on 02 Sep 2015.
Charges
A charge registered on 18 Oct 2013 via Charge ID 10456848 with Technology Development Board was fully satisfied on 24 Aug 2015.

7 earlier events are in the company report.

Frequently asked questions

Axio Biosolutions is an active private limited company based in Ahmedabad, Gujarat, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 16 May 2008 (18+ years old) and is registered under CIN U73100GJ2008PTC053905.

Axio Biosolutions has 2 current directors:

The latest financial statements of Axio Biosolutions on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Axio Biosolutions is 24AAHCA0497M1ZF, registered in Gujarat. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 29AAHCA0497M2Z4 (Karnataka).

The CIN (Corporate Identification Number) of Axio Biosolutions is U73100GJ2008PTC053905. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Axio Biosolutions has 4 court cases on record: 4 filed against it. 1 is pending.

Axio Biosolutions was incorporated on 16 May 2008, making it 18+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Axio Biosolutions has 11 deals on record (8 funding rounds, 3 secondary share transfers), with disclosed funding of ₹60.88 Cr; the latest was in October 2021.

The peers of Axio Biosolutions by revenue are Magnum Health and Safety Private Limited, Mt.Derm Medical Products Private Limited, Ashri Medico Surgicals Private Limited, all in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Sebastian Joseph Mavely ceased to be Director on 26 Aug 2019. Gourav Jagdishchandra Maheshwari ceased to be Additional Director on 28 Sep 2018. Gourav Jagdishchandra Maheshwari was appointed as Director on 16 May 2018. Axio Biosolutions has 9 board changes on record in total.

Yes, Axio Biosolutions is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0018892).